
Enveric Biosciences (NASDAQ:ENVB) a neuroscience company developing psychedelics and cannabinoids into mental health medicines, announced a collaboration with the University of Calgary’s Hotchkiss Brain Institute.
The parties will work on a clinical trial of EVM-101, a treatment based on oral psilocybin, for cancer-related distress.